Drug
Cannabis sativa flowering TOP clinical trials
Also written Cannabis Sativa.
- studies test it
- 15
- open now
- 3
- in phase 3
- 2
- first study started
- 2015
Keep track of what changes. Save the cannabis sativa flowering TOP studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2020 (5); 1 more planned to start later
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 7
- Phase 3
- 2
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 9
Assaf-Harofeh Medical Center (2) · TO Pharmaceuticals (2) · Germans Trias i Pujol Hospital (1) · New Age Ventures LLC (1) · Centre for Addiction and Mental Health (1) · University Hospital, Brest (1) · Sunnybrook Health Sciences Centre (1) · GreenCare Pharma (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cannabis sativa flowering TOP is read from its arms, and is right about nine times in ten.
Testing it · 15
- Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled StudyNot yet recruitingPhase 2University Hospital, BrestNCT06435299Written as Cannabis oil
- Using Cannabis to Treat Restless Legs SyndromeRecruitingNot applicableSunnybrook Health Sciences CentreNCT06863740Written as Cannabis oil
- Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCareRecruitingPhase 1GreenCare PharmaNCT06807762Written as Cannabis oil
- The Effects of Medical Cannabis in Children With Autistic Spectrum DisorderCompletedPhase 3Assaf-Harofeh Medical CenterNCT05212493Written as Cannabis oil
- Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant EpilepsiesWithdrawnPhase 2MGC Pharmaceuticals d.o.oNCT04406948Written as MGCND00EP1
- Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHDTerminatedPhase 2Brlev Agricultural Crops LtdNCT05219370Written as Cannabis oil
- A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum DisorderWithdrawnPhase 2TO PharmaceuticalsNCT05413187Written as Medical Grade Cannabis oil
- Cannabis Oil for Pain in Parkinson's DiseaseStatus unknownPhase 2University Health Network, TorontoNCT03639064Written as Cannabis Oil
- Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis SuppurativaWithdrawnPhase 2TO PharmaceuticalsNCT03929835Written as Cannabis oil
- Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study)WithdrawnPhase 3Assaf-Harofeh Medical CenterNCT03664141Written as Cannabis oil
- Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis PreparationCompletedPhase 1Germans Trias i Pujol HospitalNCT04841993Written as Cannabis oil
- A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy PopulationCompletedPhase 1New Age Ventures LLCNCT04601207Written as Cannabis Preparation
- Cannabis Effects on ElectroencephalographyTerminatedPhase 1Parc de Salut MarNCT04316598Written as Cannabis Sativa
- Detection of Cannabis Impairment With an Eye TrackerCompletedPhase 1/2Centre for Addiction and Mental HealthNCT03813602Written as Cannabis Sativa
- Cannabinoids Effects on the Pain Modulation SystemStatus unknownNot applicableTel-Aviv Sourasky Medical CenterNCT02560545Written as Cannabis oil
Given in every arm · 1 — cannabis sativa flowering TOP is usual care beside what is tested
Codes
What other systems call cannabis sativa flowering TOP · ClinicalTrials.gg INT015734
- UNII (FDA) 8X454SZ22DCANNABIS SATIVA FLOWERING TOPOne source FDA
- RxNorm 1484855One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8X454SZ22D | CANNABIS SATIVA FLOWERING TOP | One source FDA |
| RxNorm | 1484855 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.